N-Acetylphytosphingosine Enhances the Radiosensitivity of Tumor Cells by Increasing Apoptosis

Article Preview

Abstract:

Ceramides are well-known second messengers which mediate apoptosis, proliferation, differentiation in mammalian cells, but the physiological roles of phytosphingosines are poorly understood. We hypothesized that one of the phytosphingosine derivatives, N-acetylphytosphingosine (NAPS) can induce apoptosis in human leukemia Jurkat cell line and increase apoptosis in irradiated MDA-MB-231 cells. We first examined the effect of NAPS on apoptosis of Jurkat cells. NAPS had a more rapid and stronger apoptotic effect than C2-ceramide in Jurkat cells and significant increase of apoptosis was observed at 3 h after treatment. In contrast, the apoptosis induced by C2-ceramide was observed only after 16 h of treatment. NAPS induced apoptosis was mediated by caspase 3 and 8 activation and inhibited by z-VAD-fmk. Ceramide plays a pivotal role in radiation induced apoptosis. We postulated that exogenous treatment of NAPS sensitizes tumor cells to ionizing radiation, since NAPS might be used as a more effective alternative to C2-ceramide. As expected, NAPS decreased clonogenic survival of irradiated MDA-MB-231 cells dose dependently, and apoptosis of irradiated cells in the presence of NAPS was increased through the caspase activation. Taken together, NAPS is an effective apoptosis-inducing agent, which can be readily synthesized from yeast sources, and is a potent alternative to ceramide for the further study of ceramide associated signaling and the development of radiosensitizing agent.

You might also be interested in these eBooks

Info:

Periodical:

Key Engineering Materials (Volumes 277-279)

Pages:

536-541

Citation:

Online since:

January 2005

Export:

Price:

Permissions CCC:

Permissions PLS:

Сopyright:

© 2005 Trans Tech Publications Ltd. All Rights Reserved

Share:

Citation:

[1] A. Gewies, S.W. Rokhlin and M.B. Cohen: Lab Invest Vol. 80 (2000), p.671.

Google Scholar

[2] H. Sawai, T. Okazaki and N. Domae: FEBS Lett. Vol. 524 (2002), p.103.

Google Scholar

[3] R. Caricchio, L. D'Admio and P.L. Cohen: Cell Death. Differ. Vol. 9 (2002), p.574.

Google Scholar

[4] S. Willaime, P. Vanhoutte, J. Caboche, Y. Lemaigre-Dubreuil, J. Mariani and B. Brugg: Eur J Neurosci. Vol. 13 (2001), p. (2037).

Google Scholar

[5] H. Zhang, N.E. Buckely, K. Gilson and S. Spiegel: J Biol. Chem. Vol. 265 (1990), p.76.

Google Scholar

[6] O. Cuvillier, G. Pirianov, B. Kleuser, P.G. Vanek, O.A. Coso, So Gutkine and S. Spiegel: Nature Vol. 381 (1996), p.800.

DOI: 10.1038/381800a0

Google Scholar

[7] Y. Su, D. Rosenthal, M. Smulson and S. Spiegel: J. Biol. Chem. Vol. 269 (1994). p.16512.

Google Scholar

[8] C. Mao, J.D. Saba and L.M. Obeid: Biochem. J. Vol. 342 (1999), p.667.

Google Scholar

[9] M.S. Skrzypek, M.M. Nagiec, R.L. Lester and R.C. Dickson: J. Bacteriol. Vol. 181 (1999), p.1134.

Google Scholar

[10] O. Hwang, G. Kim, Y.J. Jang, S.W. Kim, G. Choi, H.J. Choi, S.Y. Jeon, D.G. Lee and J.D. Lee: Mol. Pharmacol. Vol. 59 (2001), p.1249.

DOI: 10.1124/mol.59.5.1249

Google Scholar

[11] J.S. Lee, D.S. Min, C. Park, C.S. Park and N.J. Cho: FEBS Lett. Vol. 499 (2001), p.82.

Google Scholar

[12] M.T. Park, J.A. Kang, J.A. Choi, C.M. Kang, T.H. Kim, S. Bae, S. Kang, S. Kim, W.I. Choi, C.K. Cho, H.Y. Chung, Y.S. Lee and S.J. Lee: Clin. Cancer Res. Vol. 9 (2003), p.878.

Google Scholar

[13] R.E. Meyn, L.C. Stephens, K.K. Ang, N.R. Hunter, W.A. Brock, L. Milas and L.J. Peters: Int. J. Radiat. Biol. Vol. 64 (1993), p.583.

Google Scholar

[14] D.D. Ling, C. Hu Dhen and W.X. Li: Radiother. Oncol. Vol. 32 (1994), p.129.

Google Scholar

[15] J. Jaffrezou, A.P. Alain, M. Andre, L. Thierry and L. Guy: FASEB Vol. 15 (2001), p.123.

Google Scholar

[16] V.E. Nava, O. Cuvillier, L.C. Edsall, K. Kimura, S. Milstien, E. P Gelmann and S. Spiegel: Cancer Res. Vol. 60 (2000), p.4468. Title of Publication (to be inserted by the publisher).

Google Scholar

[17] G. Alphonse, M.T. Aloy, P. Broquet, J.P. Gerard, P. Louisot, R. Rousson and C. RodriguezLafrasse: Int J Radiat Biol. Vol. 78 (2002), p.821.

Google Scholar

[18] L. Hunakova, M. Chorvath, J. Duraj, Z. Bartosova, L. Sevcikova, M. Sulikova, J. Chovancova, J . Sedlak, B. Chorvath and E. Boljesikova: Neoplasma Vol. 47 (2000), p.25.

DOI: 10.1002/(sici)1097-0215(19970904)72:5<916::aid-ijc33>3.0.co;2-3

Google Scholar

[19] S.J. Chmura, H.J. Mauceri, S. Advani, R. Heimann, M.A. Beckett, E. Nodzenski, J. Quintans, D.W. Kufe and R.R. Weichselbaum: Cancer Res. Vol. 57 (1997), p.4340.

Google Scholar

[20] Y. Sautin, N. Takamura, S. Shklyaev, Y. Nagayama, A. Ohtsuru, H. Namba and S. Yamashita: Thyroid Vol. 10 (2000), p.733.

DOI: 10.1089/thy.2000.10.733

Google Scholar

[21] A.P. Bruno, G. Laurent, D. Averbeck, C. Demur, J. Bonnet, A. Bettaieb, T. Levade and J.P. Jaffrezou: Cell Death Differ. Vol. 5 (1998), p.172.

DOI: 10.1038/sj.cdd.4400330

Google Scholar

[22] J.M. Michael, M.F. Lavin and D.J. Watters: Cancer Res. Vol. 57 (1997), p.3600.

Google Scholar

[23] M. Selzner, A. Bielawska, M.A. Morse, H.A. Rudiger, D. Sindram, Y.A. Hannun and P.A. Clavien: Cancer Res. Vol. 61 (2001), p.1233.

Google Scholar

[24] K. Mielke and T. Herdegen: Prog. Neurobiol. Vol. 61(2000), p.45.

Google Scholar

[25] R. Caricchio, L. D'Adamio and P.L. Cohen: Cell Death Differ. Vol. 9 (2002), p.574.

Google Scholar

[26] M. Verheij, G.A. Ruiter, S.F. Zerp, W.J. van Blitterswijk, Z. Fuks, A. Haimovitz-Friedman and H. Bartelink: Radiother. Oncol. Vol. 47 (1998), p.225.

DOI: 10.1016/s0167-8140(98)00007-3

Google Scholar

[27] M. Tomita, N. Suzuki, Y. Matsumoto, A. Enomoto, H.L. Yin, Y. Hosoi, K. Hirano and K. Sakai: Radiat. Res. Vol. 160 (2003), p.467.

Google Scholar

[28] K. Iwai, T. Kondo, M. Watanabe, T. Yabu, T. Kitano, Y. Taguchi, H. Umehara, A. Takahashi, T. Uchiyama and T. Okazaki: J. Biol. Chem. Vol. 278 (2003), p.9813.

DOI: 10.1074/jbc.m201867200

Google Scholar

[29] D.C. Phillips, K. Allen and H.R. Griffiths: Arch. Biochem. Biophys. Vol. 407 (2002), p.15.

Google Scholar